Bio
I am a Medical Oncologist specializing in genitourinary malignancies. My other interests
include cancer disparities, racial / ethnic variables in cancer care, and cancer prevention.
I practice at University Medical Center New Orleans as well as a satellite clinic
at Lallie Kemp Medical Center, a critical access hospital.
Education
Undergraduate:
George Washington University
Washington D.C.
Medical:
M.D.
George Washington University
Washington D.C.
Residency:
Emory University School of Medicine
Atlanta, Georgia
Fellowship:
Tulane University School of Medicine
New Orleans, Louisiana
Affiliated Hospitals & Clinics
- University Medical Center
- Lallie Kemp Regional Medical Center
Publications
1. Hemophagocytic Lymphohistiocytosis as the Initial Presentation of Subcutaneous Panniculitis-Like
T-Cell Lymphoma: A Rare Case Responding to Cyclosporine A and Steroids. Sullivan C,
Loghmani A, Thomas K, Jetly-Shridhar R, Chowdry RP. J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620981531. PMID: 33331177
2. A Centrocyte blood count of a quarter million. Behrens M, Chowdry RP, Saba S, Saba NS. Am J Hematol. 2017 Sep;92(9):972-973. PMID:28247462
3. MLL translocation in two castration-resistant prostate cancer patients. Chowdry RP, Ledet E, Ranasinghe L, Sartor AO. Can J Urol. 2016 Oct; 23(5):8483-8486. PMID: 27705736
4. Phosphorylated Bcl-2 and Mcl-1 as prognostic markers in small cell lung cancer. Chowdry RP, Sica GL, Kim S, Chen Z, Goodman A, Alexis D, Deng X, Owonikoko TK. Oncotarget. 2016
Feb 18. PMID: 26908449
5. Clinical Efficacy of Targeted Biologic Agents as Second-Line Therapy of Advanced Thyroid
Cancer. Owonikoko TK, Chowdry RP, Chen Z, Kim S, Saba NF, Shin DM, Khuri FR. Oncologist. 2013;18(12):1262-9. PMID:
24153240
6. Unusual suspects: pulmonary opportunistic infections masquerading as tumor metastasis
in a patient with ACTH-producing pancreatic neuroendocrine cancer. Chowdry RP, Bhimani C, Delgado MA, Lee DL, Dayamani P, Sica G, Owonikoko TK. Ther Adv Med Oncol.
2012 Nov;4(6):295-300. PMID:23118805
Research
Title: Phase Ib Study (COSMIC-021) of cabozantinib in combination with Atezolizumab
Location: LSU Health Sciences, New Orleans, Louisiana
Role: Principal Investigator
Title:Immunotherapy with Nivolumab and Ipilimumab followed by Nivolumab or Nivolumab with
Cabozantinib for patients with advanced kidney cancer, the PDIGREE study.
Location: LSU Health Sciences, New Orleans, Louisiana. National Cancer Institute
Role: Principal Investigator
Dates: 2012-2013
Title: Nivolumab in treating patients with localized kidney cancer undergoing nephrectomy
Location: LSU Health Sciences, New Orleans, Louisiana. National Cancer Institute
Role: Principal Investigator
